Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.[1][2]
References
- ^ "WHO Drug Information" (PDF). Archived from the original (PDF) on February 23, 2012.
- ^ Milne GW (2018). "6591: Felvizumab". Drugs synonyms and properties. London: Routledge Revivals. ISBN 978-1-351-78989-9.